290 related articles for article (PubMed ID: 9647538)
1. Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?
Lee C; Tummon I; Martin J; Nisker J; Power S; Tekpetey F
Hum Reprod; 1998 May; 13(5):1157-8. PubMed ID: 9647538
[TBL] [Abstract][Full Text] [Related]
2. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
3. Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients.
Al-Shawaf T; Zosmer A; Hussain S; Tozer A; Panay N; Wilson C; Lower AM; Grudzinskas JG
Hum Reprod; 2001 Jan; 16(1):24-30. PubMed ID: 11139531
[TBL] [Abstract][Full Text] [Related]
4. 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization.
Sher G; Zouves C; Feinman M; Maassarani G
Hum Reprod; 1995 Dec; 10(12):3107-9. PubMed ID: 8822423
[TBL] [Abstract][Full Text] [Related]
5. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
6. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
7. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
D'Angelo A; Brown J; Amso NN
Cochrane Database Syst Rev; 2011 Jun; (6):CD002811. PubMed ID: 21678336
[TBL] [Abstract][Full Text] [Related]
8. The prevention of ovarian hyperstimulation syndrome.
Corbett S; Shmorgun D; Claman P; ;
J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
[TBL] [Abstract][Full Text] [Related]
9. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
D'Angelo A; Brown J; Amso NN
Cochrane Database Syst Rev; 2011 Feb; (2):CD002811. PubMed ID: 21328256
[TBL] [Abstract][Full Text] [Related]
10. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
[TBL] [Abstract][Full Text] [Related]
11. Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention.
Bushaqer NJ; Dayoub NM; AlHattali KK; Ayyoub HA; AlFaraj SS; Hassan SN
Saudi Med J; 2018 Mar; 39(3):290-295. PubMed ID: 29543308
[TBL] [Abstract][Full Text] [Related]
12. Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program.
Grochowski D; Wołczyński S; Kuczyński W; Domitrz J; Szamatowicz J; Szamatowicz M
Gynecol Endocrinol; 2001 Jun; 15(3):234-8. PubMed ID: 11447736
[TBL] [Abstract][Full Text] [Related]
13. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
Prapas Y; Ravanos K; Petousis S; Panagiotidis Y; Papatheodorou A; Margioula-Siarkou C; Iuliano A; Gullo G; Prapas N
J Assist Reprod Genet; 2017 Nov; 34(11):1537-1545. PubMed ID: 28776117
[TBL] [Abstract][Full Text] [Related]
14. Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study.
Egbase PE; Sharhan MA; Grudzinskas JG
Hum Reprod; 1999 Jun; 14(6):1421-5. PubMed ID: 10357951
[TBL] [Abstract][Full Text] [Related]
15. Withholding gonadotropins until human chorionic gonadotropin administration.
Abdallah R; Kligman I; Davis O; Rosenwaks Z
Semin Reprod Med; 2010 Nov; 28(6):486-92. PubMed ID: 21082507
[TBL] [Abstract][Full Text] [Related]
16. 'Early coasting' in patients with polycystic ovarian syndrome is consistent with good clinical outcome.
Egbase PE; Al-Sharhan M; Grudzinskas JG
Hum Reprod; 2002 May; 17(5):1212-6. PubMed ID: 11980740
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
18. "Coasting" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
D'Angelo A; Amso N
Cochrane Database Syst Rev; 2002; (3):CD002811. PubMed ID: 12137659
[TBL] [Abstract][Full Text] [Related]
19. Symposium: Update on prediction and management of OHSS. Prevention of OHSS.
Aboulghar M
Reprod Biomed Online; 2009 Jul; 19(1):33-42. PubMed ID: 19573288
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study.
Lewit N; Kol S; Manor D; Itskovitz-Eldor J
Hum Reprod; 1996 Jul; 11(7):1399-402. PubMed ID: 8671474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
